Teladoc Health, Inc. (TDOC) stock
Close on Nov 12, 2026Market cap $1.58BP/E –Yield –
Teladoc Health, Inc. saw revenue fall 2.4% to $2.47B over the twelve months to Sep 30, 2026. Free cash flow was $261.96M, down 6.5% from a year earlier. At the latest close the market valued the company at $1.58B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.58B
- P/E ratio
- –
- Price to sales
- 0.64
- Price to book
- 1.22
- Dividend yield
- –
- Free cash flow yield
- 16.54%
Fundamentals
- Revenue
- $2.47B
- Net income
- -$154.82M
- EPS, diluted
- -$0.86
- Free cash flow
- $261.96M
- Book value per share
- $7.12
- Diluted shares
- 182M
Trading
- Next earnings
- Feb 24, 2027 (estimated, after the close)
- Previous close
- $8.94
- Open
- $8.82
- Day's range
- $8.64 – $8.94
- Volume
- 3,142,129
- Average volume (20 days)
- 5,689,407
- Index membership
- Russell 2000 (since Sep 2024), Russell 3000
- Beta (5 years)
- 1.97
- 52-week range
- $4.40 – $9.89
- RSI (14 days)
- 63.7
- Volatility (1 year)
- 66.1%
- Relative volume
- 0.69×
- WACC
- 14.8%
On 2 of our idea lists: More cash than they're worth, Most shorted (a warning list)
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | TDOC | S&P 500 | Difference | TDOC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +46.8% | -2.7% | +49.5 pts | ||
| 3 months | +29.5% | -1.7% | +31.3 pts | ||
| Year to date | +24.1% | +11.9% | +12.2 pts | ||
| 1 year | +16.3% | +12.0% | +4.3 pts | ||
| 3 years | -45.5% | +78.2% | −123.7 pts | -18.3% | +21.2% |
| 5 years | -93.6% | +73.2% | −166.9 pts | -42.3% | +11.6% |
| 10 years | -51.5% | +309.6% | −361.1 pts | -7.0% | +15.1% |
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Teladoc Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Results
- Update
About Teladoc Health
Services-Offices & Clinics of Doctors of Medicine
Teladoc Health provides virtual healthcare services that connect patients with medical professionals for remote clinical care. The company operates through two main segments: Integrated Care and BetterHelp. Its Integrated Care segment offers primary care, urgent care, chronic disease management, mental health services, and medical second opinions, alongside telehealth software and connected devices for health systems. Its BetterHelp segment provides online therapy, counseling, and sleep wellness applications. The company serves individual consumers as well as institutional clients, including employers, health plans, hospital networks, and financial institutions.
Company profile, executives and historyTeladoc Health stock: common questions
What is Teladoc Health's stock price?
TDOC closed at $8.69 on Nov 12, 2026, down 2.80% on the day. Over the past 52 weeks it traded between $4.40 and $9.89.
What is Teladoc Health's market cap?
Teladoc Health was worth $1.58B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is TDOC's P/E ratio?
Teladoc Health lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.86), so it has no meaningful P/E ratio.
How much revenue does Teladoc Health make?
Teladoc Health reported revenue of $2.47B for the twelve months to Sep 30, 2026, down 2.4% from a year earlier.
Does Teladoc Health pay a dividend?
No. Teladoc Health has not paid a cash dividend over the last twelve months.
When does Teladoc Health report earnings next?
Teladoc Health is expected to report Q4 FY2026 results on Feb 24, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has TDOC stock performed over the past year?
Including dividends, TDOC returned +16.3% over the past year, against +12.0% for the S&P 500.
How many TDOC shares are sold short?
32M shares were sold short at the latest FINRA report, 17.79% of the float, or 5.7 days of average trading volume.
Who are Teladoc Health's competitors?
Companies most similar to Teladoc Health by business, industry and size include HIMS, AUNA, LFMD, PRVA, CCM.
See a number that looks wrong?